Esperion Therapeutics, Inc. (ESPR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.64
Day's range
$3.06

Esperion Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GLAZER CAPITAL, LLC 08/17/2026 22.42 M $70.84 M   100.00% 8.92%
BLACKROCK, INC. 08/07/2026 22.13 M $69.92 M   23.95% 8.80%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 11.43 M $36.11 M   9.52% 4.55%
TRIUM CAPITAL LLP 07/16/2026 11.16 M $35.26 M   100.00% 4.44%
GOLDMAN SACHS GROUP INC 08/14/2026 10.38 M $32.80 M   330.65% 4.13%
STATE STREET CORP 08/07/2026 7.28 M $22.99 M   3.12% 2.89%
TWO SIGMA INVESTMENTS, LP 08/14/2026 7.13 M $22.52 M   -24.65% 2.84%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 6.63 M $20.96 M   11.32% 2.64%
AQR ARBITRAGE LLC 08/14/2026 6.05 M $19.11 M   100.00% 2.41%
ODDO BHF ASSET MANAGEMENT SAS 08/13/2026 5.00 M $15.80 M   100.00% 1.99%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 4.65 M $14.71 M   100.00% 1.85%
FMR LLC 08/13/2026 4.61 M $14.58 M   1,131.76% 1.84%
BERYL CAPITAL MANAGEMENT LLC 08/14/2026 4.43 M $14.00 M   100.00% 1.76%
PENDERFUND CAPITAL MANAGEMENT LTD. 08/17/2026 3.88 M $12.28 M   -0.19% 1.55%
UBS GROUP AG 08/13/2026 3.84 M $12.12 M   -10.61% 1.53%
ALLIANCEBERNSTEIN L.P. 08/14/2026 3.59 M $9.83 M   1,270.61% 1.43%
PSQUARED ASSET MANAGEMENT AG 08/17/2026 3.30 M $10.43 M   100.00% 1.31%
NEXPOINT ASSET MANAGEMENT, L.P. 08/14/2026 2.96 M $9.34 M   100.00% 1.18%
GABELLI FUNDS LLC 08/12/2026 2.88 M $9.10 M   100.00% 1.15%
TIG ADVISORS, LLC 08/14/2026 2.59 M $8.18 M   100.00% 1.03%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 2.47 M $7.81 M   -30.03% 0.98%
NORTHERN TRUST CORP 08/13/2026 2.32 M $7.34 M   10.35% 0.92%
GABELLI & CO INVESTMENT ADVISERS, INC. 08/12/2026 2.32 M $7.32 M   100.00% 0.92%
MILLENNIUM MANAGEMENT LLC 08/14/2026 2.23 M $7.03 M   268.29% 0.89%
SAGEFIELD CAPITAL LP 08/14/2026 2.19 M $6.92 M   100.00% 0.87%
FIL LTD 08/13/2026 2.11 M $6.66 M   100.00% 0.84%
WASATCH ADVISORS LP 07/10/2026 1.93 M $6.10 M   -87.76% 0.77%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.74 M $5.49 M   11.08% 0.69%
CARMIGNAC GESTION 08/13/2026 1.66 M $5.24 M   100.00% 0.66%
LMR PARTNERS LLP 08/14/2026 1.61 M $5.08 M   4,381.93% 0.64%
TRANSMARKET HOLDINGS LP 07/21/2026 1.59 M $5.03 M   100.00% 0.63%
VOLEON CAPITAL MANAGEMENT LP 08/14/2026 1.55 M $4.89 M   -19.18% 0.62%
POLAR ASSET MANAGEMENT PARTNERS INC. 08/14/2026 1.51 M $4.77 M   100.00% 0.60%
ALPINE ASSOCIATES MANAGEMENT INC. 08/06/2026 1.50 M $4.74 M   100.00% 0.60%
JPMORGAN CHASE & CO 08/12/2026 1.40 M $4.40 M   103.72% 0.56%
GARDNER LEWIS ASSET MANAGEMENT L P 08/12/2026 1.37 M $4.31 M   100.00% 0.54%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 1.27 M $4.00 M   100.00% 0.50%
MAVEN SECURITIES LTD 08/14/2026 1.24 M $3.93 M   100.00% 0.50%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/14/2026 1.14 M $3.61 M   100.00% 0.45%
CREDIT INDUSTRIEL ET COMMERCIAL 07/24/2026 1.04 M $3.30 M   100.00% 0.42%
CAPULA MANAGEMENT LTD 08/14/2026 930.16 K $2.94 M   100.00% 0.37%
WEISS ASSET MANAGEMENT LP 08/14/2026 847.12 K $2.68 M   100.00% 0.34%
CHICAGO CAPITAL MANAGEMENT, LLC 07/22/2026 830.94 K $2.61 M   100.00% 0.33%
VESTCOR INC 08/11/2026 800.00 K $2.53 M   100.00% 0.32%
SOROS FUND MANAGEMENT LLC 08/14/2026 757.36 K $2.39 M   100.00% 0.30%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 742.25 K $2.35 M   10.74% 0.30%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 742.25 K $2.35 M   100.00% 0.30%
BANK OF NEW YORK MELLON CORP 08/06/2026 732.62 K $2.32 M   31.96% 0.29%
MORGAN STANLEY 08/13/2026 700.67 K $2.21 M   -74.39% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 657.44 K $2.08 M   -22.70% 0.26%

Esperion Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 345 institutional investors and hedge funds held shares of Esperion Therapeutics Inc.. The most heavily invested institutionals were:

GLAZER CAPITAL, LLC: 22.42 M

BlackRock, Inc.: 22.13 M

VANGUARD CAPITAL MANAGEMENT LLC: 11.43 M

Trium Capital LLP: 11.16 M

GOLDMAN SACHS GROUP INC: 10.38 M

STATE STREET CORP: 7.28 M

80.91% of Esperion Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 249.24 M shares in the last 24 months. This purchase volume represents approximately $757.69 M in transactions.